Emergency Medicine Doctors in Durand, WI Accepting Medicare
5 Emergency Medicine doctors found. Showing 1 - 5
 Thomas K. Hunt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 3rd Ave W, Durand, WI 54736 Phone: 715-672-5233 |
Robert L Dohlman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 7th Ave W, Durand, WI 54736 Phone: 715-672-5981 |
Joseph L. Elsner, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 905 7th Ave W, Durand, WI 54736 Phone: 715-672-5981 |
 Robyn L Sandin, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 7th Ave W, Durand, WI 54736 Phone: 715-672-5981 |
Joseph Williams, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1220 3rd Ave W, Durand, WI 54736 Phone: 715-672-4211 |
News Archive
NIH researchers develop new tool to better understand brain disorders
A new tool developed by researchers at the National Institutes of Health has determined, for the first time, how two distinct sets of neurons in the mouse brain work together to control movement.
Study shows link between astronauts' weight and post-flight eye changes
New research suggests that changes in the eye that occur during spaceflight may be related to how much an astronaut weighs. The study is published ahead of print in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
Thermo Fisher signs asset purchase agreement with Nephromics for PlGF assay
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
Emerging protein-based immunotherapies could lead to highly effective cancer treatments
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
› Verified 8 days ago